Literature DB >> 21568913

Regional grey matter loss and brain disconnection across Alzheimer disease evolution.

M Bozzali1, A Padovani, C Caltagirone, B Borroni.   

Abstract

It is becoming increasingly clearer that the clinical manifestations of Alzheimer's disease (AD) are not only associated with regional grey matter (GM) damage, but also with abnormal integration between cortical brain regions by disconnection mechanism. This concept comes from the evidence that white matter (WM) damage (as assessed by diffusion MR imaging) can be observed in patients with AD since the early clinical stages, and it correlates with clinical measures of cognitive disability. In this perspective, several functional imaging studies, based on PET and resting state fMRI, have provided evidence that brain hypometabolism/disconnection may precede the occurrence of GM atrophy in certain regions of AD brains, such as the cingulate cortex. The cingulum represents the most prominent WM tract of the limbic system, being directly connected to the medial temporal lobe structures. Therefore, this structure likely contributes to changes in functional connectivity observed within the so called default-mode network of AD patients, and its damage is likely to play a remarkable role in the conversion from mild cognitive impairment (MCI) to dementia. Nowadays, the combination of several neuroimaging techniques that provide both, measures of regional GM loss and measures of functional and structural connectivity offer the opportunity to investigate in vivo the pathophysiological changes of brain tissue modifications across the clinical evolution of AD. This paper reviews the main MR based methods of investigation of brain tissue involvement in patients with AD and MCI, and the role they have played in clarifying the differential contribution of GM damage and brain disconnection to AD pathophysiology. This subject seems to be relevant for both, speculative aspects of neurology and application to clinical trials.

Entities:  

Mesh:

Year:  2011        PMID: 21568913     DOI: 10.2174/092986711795843263

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  26 in total

Review 1.  Axonal degeneration in Alzheimer's disease: when signaling abnormalities meet the axonal transport system.

Authors:  Nicholas M Kanaan; Gustavo F Pigino; Scott T Brady; Orly Lazarov; Lester I Binder; Gerardo A Morfini
Journal:  Exp Neurol       Date:  2012-06-19       Impact factor: 5.330

2.  Dopaminergic modulation of cortical plasticity in Alzheimer's disease patients.

Authors:  Giacomo Koch; Francesco Di Lorenzo; Sonia Bonnì; Viola Giacobbe; Marco Bozzali; Carlo Caltagirone; Alessandro Martorana
Journal:  Neuropsychopharmacology       Date:  2014-05-26       Impact factor: 7.853

Review 3.  Diffusion magnetic resonance imaging for Brainnetome: a critical review.

Authors:  Nianming Zuo; Jian Cheng; Tianzi Jiang
Journal:  Neurosci Bull       Date:  2012-08       Impact factor: 5.203

4.  The default mode network and related right hemisphere structures may be the key substrates of dementia.

Authors:  Donald R Royall; Raymond F Palmer; Eric D Vidoni; Robyn A Honea; Jeffrey M Burns
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

5.  Abnormal dynamic functional connectivity and brain states in Alzheimer's diseases: functional near-infrared spectroscopy study.

Authors:  Haijing Niu; Zhaojun Zhu; Mengjing Wang; Xuanyu Li; Zhen Yuan; Yu Sun; Ying Han
Journal:  Neurophotonics       Date:  2019-06-04       Impact factor: 3.593

Review 6.  Neurotoxic saboteurs: straws that break the hippo's (hippocampus) back drive cognitive impairment and Alzheimer's Disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2013-07-03       Impact factor: 3.911

7.  Association of Central Arterial Stiffness and Pressure Pulsatility with Mild Cognitive Impairment and Dementia: The Atherosclerosis Risk in Communities Study-Neurocognitive Study (ARIC-NCS).

Authors:  Michelle L Meyer; Priya Palta; Hirofumi Tanaka; Jennifer A Deal; Jacqueline Wright; David S Knopman; Michael E Griswold; Thomas H Mosley; Gerardo Heiss
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

8.  Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's disease.

Authors:  Claudio Liguori; Agostino Chiaravalloti; Marzia Nuccetelli; Francesca Izzi; Giuseppe Sancesario; Andrea Cimini; Sergio Bernardini; Orazio Schillaci; Nicola Biagio Mercuri; Placidi Fabio
Journal:  J Neurol       Date:  2017-09-12       Impact factor: 4.849

9.  Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints.

Authors:  Agnese Picco; M Cristina Polidori; Michela Ferrara; Roberta Cecchetti; Dario Arnaldi; Mauro Baglioni; Silvia Morbelli; Patrizia Bastiani; Irene Bossert; Giuliana Fiorucci; Andrea Brugnolo; Massimo Eugenio Dottorini; Flavio Nobili; Patrizia Mecocci
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-12-03       Impact factor: 9.236

10.  How genetics affects the brain to produce higher-level dysfunctions in myotonic dystrophy type 1.

Authors:  Laura Serra; Antonio Petrucci; Barbara Spanò; Mario Torso; Giusy Olivito; Ludovico Lispi; Sandro Costanzi-Porrini; Giovanni Giulietti; Giacomo Koch; Manlio Giacanelli; Carlo Caltagirone; Mara Cercignani; Marco Bozzali
Journal:  Funct Neurol       Date:  2015 Jan-Mar
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.